Company profile
Enovis Corporation functions as a global medical technology enterprise, specializing in the design, manufacturing, and distribution of advanced medical device solutions. These products are utilized by a broad spectrum of healthcare professionals worldwide, including orthopedic specialists, surgeons, primary care physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers. Their offerings are geared towards treating patients suffering from musculoskeletal conditions that arise from degenerative diseases, deformities, traumatic events, or sports-related injuries. The company's extensive portfolio encompasses a variety of products such as rigid and soft orthopedic braces, hot and cold therapy items, bone growth stimulators, vascular therapy systems complemented by compression garments, therapeutic footwear and inserts, electrical stimulators for pain relief, and various physical therapy aids. Additionally, Enovis provides a comprehensive range of reconstructive joint products for crucial areas like the hip, knee, shoulder, elbow, foot, ankle, and fingers. Products are sold through a network of independent distributors, which includes other healthcare professionals, consumer retail stores, and pharmacies, as well as directly to consumers, notably under the DJO brand. The company, formerly known as Colfax Corporation, is headquartered in Wilmington, Delaware.
- CEO
- Damien McDonald
- Employees
- 7,802
- IPO date
- 08 May 2008
- ISIN
- US1940145022
